On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Redoxis AB's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€922k · 3 projects
- Horizon 2020€677k · 3 projects
Projects
6 EU-funded projects, newest first. Each links to the official record.
- NeutroCurePartner
Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€400ktheir share - COSMICPartner
COmbatting disorders of adaptive immunity with Systems MedICine
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€264ktheir share - REDOXITPartner
Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils.
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€14ktheir share - NEURINOXPartner
NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€771ktheir share - €1ktheir share
- MASTERSWITCHPartner
Mechanisms to Attack Steering Effectors of Rheumatoid Syndromes with Innovated Therapy Choices
FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗
€150ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Karolinska InstitutetSweden · 4 shared projects
- Universitatsklinikum ErlangenGermany · 3 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- King'S College LondonUnited Kingdom · 2 shared projects
- University of LeedsUnited Kingdom · 2 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 2 shared projects
- University of GlasgowUnited Kingdom · 2 shared projects
- Medizinische Universitaet WienAustria · 2 shared projects
- Friedrich-Alexander-Universitaet Erlangen-NuernbergGermany · 2 shared projects
- University of SurreyUnited Kingdom · 2 shared projects
- Universitat ZurichSwitzerland · 2 shared projects
- Academisch Medisch Centrum Bij de Universiteit van AmsterdamNetherlands · 2 shared projects
- Idryma Iatroviologikon Ereunon Akademias AthinonGreece · 2 shared projects
- Erevnitiko Kentro Vioiatrikon Epistimon Alexandros FlemingkGreece · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- alkaline earth metals
- amyotrophic lateral sclerosis
- autoimmune diseases
- drug discovery
- enzymes
- immunology
- inflammatory diseases
- multiple sclerosis
- oncology
- proteomics
- rheumatology
Redoxis AB is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
